AY
Ao Yang
Director, Biomolecular Sciences at Ikena Oncology
View Ao's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Jan 2022 - Present · 2 years and 11 months
Director, Biomolecular Sciences
Jun 2023 - Present · 1 years and 6 months
Associate Director, Structural Biology
Jan 2022 - Jun 2023 · 1 years and 5 months
Associate Director
Aug 2021 - Jan 2022 · 5 months
Company Details
51-200 Employees
Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Our programs focus on key cancer driver pathways that are well-validated in scientific literature but lack approved or effective therapies and therefore have the potential to address high unmet medical needs. By leveraging our deep understanding of discovery chemistry, translational science, and patient-centric drug development, we have built a deep pipeline of wholly owned and partnered programs focused on genetically defined or biomarker-driven cancers, which enables us to target specific patient populations that we believe are most likely to respond to treatment with our product candidates. We have assembled an experienced and well-respected team of drug hunters, translational researchers, clinicians and entrepreneurs drawn from many of the largest innovators in biotechnology, supported by top-tier investors and partners, as well as world-class advisors, to advance and broaden our portfolio of novel, patient-directed oncology therapies.
Year Founded
2016
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
645 Summer Street Suite 101 Boston, Massachusetts 02210, US
Keywords
Targeted Oncologycancer therapeutics developmentsmall molecule drug desigcancer biologytranslational science and biomarkers
Discover More About Cleveland Clinic

Find verified contacts of Ao Yang in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.